Search for: "RANBAXY PHARMACEUTICALS, INC." Results 21 - 40 of 101
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
25 Nov 2012, 8:36 pm
A generic form of the cholesterol lowering drug Lipitor is now being recalled by India-based Ranbaxy Pharmaceuticals Inc. because small glass particles may be in select batches. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
District Court for the District of New Jersey concerning Wyeth Pharmaceuticals Inc. [read post]
29 Aug 2012, 3:15 am by Lawrence B. Ebert
Ranbaxy Pharmaceuticals, Inc., 336 F.3d 1322, 1330 (Fed. [read post]
15 Aug 2012, 11:02 am by FDABlog HPM
According to Watson, “[b]ased on the simultaneous filing of the Watson ANDA with Mylan and Ranbaxy’s ANDAs, Watson has expected to share the period of 180-day exclusivity with Mylan and Ranbaxy (as well as with a fourth generic manufacturer, Teva Pharmaceuticals (‘Teva’), that has been granted a license by Takeda). [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Ranbaxy's Lipitor-copy goes on sale 1 Dec 2011, but the impact on consumers is a bit more complicated than one might think.For example, Watson Pharmaceuticals is selling a Lipitor copy under an agreement made with patentee Pfizer (thus, an authorized generic). [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
20 Jul 2011, 4:04 am by Marie Louise
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid… [read post]
3 May 2011, 7:16 am by Zoe Tillman
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
26 Apr 2011, 11:15 pm
Ranbaxy Laboratories manufactured an Accutane version called Sotret which has been withdrawn. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]